New drug cocktail aims to cut breathing risks during sedation in seniors

NCT ID NCT07376577

Not yet recruiting Symptom relief Sponsor: The First Affiliated Hospital of Xinxiang Medical College Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a new drug combination (anricofen plus ciprofol) can provide safer deep sedation for elderly patients undergoing ERCP, a procedure to treat bile duct problems. The goal is to reduce breathing complications and speed up recovery compared to the standard sedative mix. About 141 patients aged 60-90 will take part, receiving one of two doses of the new combo or the standard treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Anricofen and Ciprofol
What this could lead to: If successful, this could offer a safer sedation option for elderly patients undergoing ERCP, with fewer breathing problems and faster recovery.
What could go wrong: This is a small, early-stage trial with only 141 participants. The new drug combination may not prove safer or more effective than current methods, and unexpected side effects are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANESTHESIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

channelopathy-associated congenital insensitivity to pain, autosomal recessive

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANESTHESIA CIPROFOL ERCP SEDATION

More trials for these conditions

Other studies related to the condition(s) this trial covers.